Recent Posts
- Montelukast oral film may help in mild to moderate Alzheimer’s July 25, 2024
- Lomecel-B granted FDA RMAT status for mild Alzheimer’s July 18, 2024
- FDA clears foralumab nasal spray for expanded use in Alzheimer’s July 11, 2024
- FDA approves donanemab, now Kisunla, to treat early Alzheimer’s July 3, 2024
- Buntanetap found effective, safe in early Alzheimer’s trial: New data June 27, 2024